Partha Seshaiah

Maxygen (United States)

Papers

1

Total Citations

5

H-Index

1

About

Dr. Partha Seshaiah is a pioneering interventional oncologist whose research focuses on the safety and efficacy of novel tumor ablation technologies, particularly pulsed electric field (PEF) ablation, for treating metastatic cancer. His most notable contribution is the landmark study "The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer" (2025), which demonstrated that PEF ablation can be safely performed during diagnostic lung biopsies before patients begin first-line standard-of-care therapy. This work, already garnering 5 citations, represents a critical step toward integrating minimally invasive ablation techniques into early cancer treatment paradigms. Dr. Seshaiah's research addresses the urgent need for safer, non-thermal ablation methods that spare surrounding healthy tissue while effectively targeting metastatic lesions. His clinical investigations bridge the gap between diagnostic procedures and therapeutic intervention, potentially reducing treatment delays and improving outcomes for patients with advanced malignancies. Through his rigorous safety evaluations and innovative procedural approaches, Dr. Seshaiah is helping to redefine the standard of care for metastatic cancer patients, offering new hope for those with limited treatment options.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Maxygen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago